fluorescein has been researched along with Cancer of Prostate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Gao, Y; Liu, Y; Wang, B; Wu, Y; Xu, B; Zhou, H | 1 |
| Huang, T; Kang, J; Li, C; Liu, X; Wang, H | 1 |
| Beloglazkina, EK; Dashkova, NS; Fedorova, OA; Gerasimov, VM; Grishina, IV; Ignatov, PA; Jonusauskas, G; Kireev, II; Kovalev, SS; Krasnovskaya, OO; Lavrushkina, SV; Majouga, AG; Malinnikov, VM; Panchenko, PA; Skvortsov, DA; Zakharko, MA; Zyk, NV | 1 |
| Deeg, M; Echner, H; Ernemann, U; Heckl, S; Horger, M; Nägele, T; Schwentner, C; Sheikh, S; Sturzu, A | 1 |
| Brown, TR; Graham, MK; Miller, PS | 1 |
| Buckle, T; KleinJan, GH; van den Berg, NS; van der Poel, HG; van Leeuwen, FWB | 1 |
| Al-Zahrani, A; Autran-Gomez, AM; Chan, S; Chin, JL; Gomez-Lemus, J; Izawa, JI; Lewis, JD; Lu, C; Luyt, LG; McFarland, MS; Nesbitt, RL; Williams, AK | 1 |
| Darcy, R; Desgranges, S; Guo, J; O'Driscoll, C; Ogier, JR | 1 |
| Chang, A; Chib, R; Fudala, R; Gryczynski, I; Gryczynski, Z; Mummert, M; Raut, S; Rich, R | 1 |
| Dechsukhum, C; Dumur, CI; Ferreira-Gonzalez, A; Garrett, CT; Ware, JL; Wilkinson, DS | 1 |
| Hescheler, J; Sauer, H; Schallenberg, M; Wartenberg, M | 1 |
| Klibanov, AL; Lu, E; Modzelewski, RA; Villanueva, FS; Wagner, WR; Weller, GE; Wong, MK | 1 |
| Anezinis, P; Castanas, E; Dambaki, C; Darivianaki, K; Kampa, M; Kogia, C; Nomikos, M; Stathopoulos, EN; Theodoropoulos, PA | 1 |
| Bolton, WE; Crumpler, DC; Jacobberger, JW; Sramkoski, RM; Wormsley, SW | 1 |
| Clayman, GL; Hong, FD | 1 |
15 other study(ies) available for fluorescein and Cancer of Prostate
| Article | Year |
|---|---|
Targeted fluorescent imaging of a novel FITC-labeled PSMA ligand in prostate cancer.
Topics: Antigens, Surface; Cell Line, Tumor; Fluorescein; Fluorescein-5-isothiocyanate; Humans; Ligands; Male; Prostatic Neoplasms | 2022 |
Construction of Fluorescein Isothiocyanate-Labeled MSNs/PEG/Lycorine/Antibody as Drug Carrier for Targeting Prostate Cancer Cells.
Topics: Amaryllidaceae Alkaloids; Antibodies; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Fluorescein; Humans; Isothiocyanates; Male; Nanocomposites; Nanoparticles; Phenanthridines; Prostatic Neoplasms | 2018 |
Thiourea Modified Doxorubicin: A Perspective pH-Sensitive Prodrug.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Fluorescein; Fluorescence Resonance Energy Transfer; Humans; Hydrogen-Ion Concentration; Male; Naphthalenes; Prodrugs; Prostatic Neoplasms; Thiourea | 2019 |
Novel bourgeonal fragrance conjugates for the detection of prostate cancer.
Topics: Aldehydes; Animals; Cell Line, Tumor; Fluorescein; Fluorescent Dyes; Humans; Male; Mice; Perfume; Prostatic Neoplasms; Receptors, Odorant; Rhodamines; RNA, Messenger; Seminal Plasma Proteins | 2013 |
Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides.
Topics: Cell Line, Tumor; Cross-Linking Reagents; Fluorescein; Fluorescent Dyes; Gene Knockdown Techniques; Glutathione; Humans; Male; Microscopy, Fluorescence; Molecular Targeted Therapy; Oligonucleotides; Organoplatinum Compounds; Polymerase Chain Reaction; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Transfection | 2015 |
Multispectral Fluorescence Imaging During Robot-assisted Laparoscopic Sentinel Node Biopsy: A First Step Towards a Fluorescence-based Anatomic Roadmap.
Topics: Aged; Equipment Design; Feasibility Studies; Fluorescein; Fluorescent Dyes; Humans; Indocyanine Green; Laparoscopes; Laparoscopy; Lymphography; Male; Middle Aged; Optical Imaging; Pilot Projects; Predictive Value of Tests; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Robotics; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2017 |
Ghrelin receptor as a novel imaging target for prostatic neoplasms.
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Cell Line; Cell Line, Tumor; Diagnosis, Differential; Fluorescein; Ghrelin; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Ghrelin; Sensitivity and Specificity | 2012 |
Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Benzamides; beta-Cyclodextrins; Cell Death; Cell Line, Tumor; Endocytosis; Fluorescein; Gene Silencing; Gene Transfer Techniques; Genes, Reporter; Humans; Intracellular Space; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Prostatic Neoplasms; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2012 |
FRET based ratio-metric sensing of hyaluronidase in synthetic urine as a biomarker for bladder and prostate cancer.
Topics: Biomarkers, Tumor; Fluorescein; Fluorescence; Fluorescence Resonance Energy Transfer; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Prostatic Neoplasms; Rhodamines; Urinary Bladder; Urinary Bladder Neoplasms; Urine | 2013 |
Analytical validation of a real-time reverse transcription-polymerase chain reaction quantitation of different transcripts of the Wilms' tumor suppressor gene (WT1).
Topics: Calibration; DNA Primers; Exons; Fluorescein; Fluorescent Dyes; Genes, Wilms Tumor; Humans; Introns; Male; Middle Aged; Oligonucleotide Probes; Prostatic Neoplasms; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; WT1 Proteins | 2002 |
Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids.
Topics: Antioxidants; Apoptosis; Arginine; Benzoates; Buthionine Sulfoximine; Caspase 3; Caspases; Enzyme Inhibitors; Epidermal Growth Factor; Fluorescein; Free Radical Scavengers; Humans; Hydrogen Peroxide; Imidazoles; Immunoenzyme Techniques; Indicators and Reagents; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured; Vitamin E | 2003 |
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.
Topics: Animals; Arginine; Carcinoma, Squamous Cell; Echocardiography; Endothelium, Vascular; Fluorescein; Humans; Leucine; Male; Mice; Mice, Inbred C3H; Mice, Nude; Microbubbles; Myocardium; Neoplasm Transplantation; Neovascularization, Pathologic; NIH 3T3 Cells; Oligopeptides; Prostatic Neoplasms; Transplantation, Heterologous | 2005 |
Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections.
Topics: Adult; Aged; Aged, 80 and over; Binding Sites; Biomarkers, Tumor; Cell Differentiation; Cell Membrane; Fluorescein; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Paraffin; Prostatic Neoplasms; Receptors, Androgen; Reproducibility of Results; Steroids | 2005 |
Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate.
Topics: Benzimidazoles; Cell Cycle; Cell Line; Cell Separation; Cells, Immobilized; Cyclin B; Cyclin B1; DNA; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescein; Fluorescein-5-isothiocyanate; Formaldehyde; Humans; Immunohistochemistry; Male; Methanol; Prostatic Neoplasms; Retinoblastoma Protein; Time Factors; Tumor Cells, Cultured | 1999 |
Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.
Topics: Amino Acid Sequence; Animals; Astrocytoma; Carcinoma, Squamous Cell; Cell Membrane; Colonic Neoplasms; Contrast Media; Drug Carriers; Drug Delivery Systems; Female; Fluorescein; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Molecular Sequence Data; Oligopeptides; Prostatic Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2000 |